Barbara Lubiszewska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Barbara Lubiszewska has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Piotr Szymański
Department of Acquired Cardiac Defects, Institute of Cardiology, Warsaw, Poland
10 shared publications Marcin Demkow
Natl Inst Cardiol, Dept Coronary & Struct Heart Dis, Ul Alpejska 42, PL-04628 Warsaw, Poland
9 shared publicationsW Ruzyłło
8 shared publicationsPiotr Hoffman
7 shared publicationsMariusz Kruk
Natl Inst Cardiol, Dept Coronary & Struct Heart Dis, Ul Alpejska 42, PL-04628 Warsaw, Poland
6 shared publicationsJ Kuch
5 shared publications
Latest Publications
- 25 June 2020
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 130 (9) , 748-756
The association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and the plasma fibrinogen level in women and men with premature coronary artery atherosclerosis
DOI: 10.20452/pamw.15461, Published online: June 25, 2020, Authors: Karolina E. Kryczka, Rafał Płoski, Ewa Księżycka, Mariusz Kruk, Grażyna Kostrzewa, Ilona Kowalik, Marcin Demkow, Barbara Lubiszewska
- 25 June 2020
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 130 (9) , 748-756
The association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and the plasma fibrinogen level in women and men with premature coronary artery atherosclerosis
DOI: 10.20452/pamw.15461, Published online: June 25, 2020, Authors: Karolina E. Kryczka, Rafał Płoski, Ewa Księżycka, Mariusz Kruk, Grażyna Kostrzewa, Ilona Kowalik, Marcin Demkow, Barbara Lubiszewska
- Open Access
- 21 November 2018
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 8, 540
Giant Intrapericardial Myxoma Adjacent to the Left Main Coronary Artery
A 62-years-old woman was admitted to the hospital because of chronic cough, expectoration of thick mucus, hoarseness and tightness in the precordial area. Computed Tomography (CT) examination revealed the presence of a giant intrapericardial tumor with the dimensions of 80 × 38 × 32 mm. It was located anteriorly and laterally to the left atrium, posteriorly to the pulmonary trunk and the ascending aorta. This hypodense change modeled the left atrium without evidence of invasion. CT coronary angiography and 3-dimensional reconstruction were applied to enable precise planning of cardiac surgery. CT evaluation confirmed that it is possible to remove the tumor without damage to the adjacent left main coronary artery. The patient underwent cardiac surgery with sternotomy and cardiopulmonary bypass. A cohesive, smooth, vascularized tumor pedunculated to the left atrial epicardium was visualized. The location and dimensions corresponded to those determined by CT scan examination. The entire tumor was successfully dissected together with adjacent adipose and fibrous tissue. Histological evaluation revealed the presence of myxoid cells, blood vessels, degenerative changes, and microcalcifications embedded in profuse hyalinized stroma. Those histological features enabled identification of the intrapericardial tumor as a myxoma. Follow-up CT examination did not demonstrate any signs of recurrence of the myxoma. According to our knowledge, a myxoma located inside the pericardial sac has never been described before.
- 21 November 2018
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 8, 540
Open AccessGiant Intrapericardial Myxoma Adjacent to the Left Main Coronary Artery
A 62-years-old woman was admitted to the hospital because of chronic cough, expectoration of thick mucus, hoarseness and tightness in the precordial area. Computed Tomography (CT) examination revealed the presence of a giant intrapericardial tumor with the dimensions of 80 × 38 × 32 mm. It was located anteriorly and laterally to the left atrium, posteriorly to the pulmonary trunk and the ascending aorta. This hypodense change modeled the left atrium without evidence of invasion. CT coronary angiography and 3-dimensional reconstruction were applied to enable precise planning of cardiac surgery. CT evaluation confirmed that it is possible to remove the tumor without damage to the adjacent left main coronary artery. The patient underwent cardiac surgery with sternotomy and cardiopulmonary bypass. A cohesive, smooth, vascularized tumor pedunculated to the left atrial epicardium was visualized. The location and dimensions corresponded to those determined by CT scan examination. The entire tumor was successfully dissected together with adjacent adipose and fibrous tissue. Histological evaluation revealed the presence of myxoid cells, blood vessels, degenerative changes, and microcalcifications embedded in profuse hyalinized stroma. Those histological features enabled identification of the intrapericardial tumor as a myxoma. Follow-up CT examination did not demonstrate any signs of recurrence of the myxoma. According to our knowledge, a myxoma located inside the pericardial sac has never been described before.
- 1 April 2018
- Published by Wolters Kluwer Health in Menopause
- Vol. 25 (4) , 408-414
Menopause improves the predictive value of common cardiovascular risk scores in women with premature coronary artery disease
Objective: Menopause, particularly its early stage (<= 3 years from onset), may be an important risk factor for premature coronary artery disease. The objective of the study was to assess whether the addition of the presence of menopause in women with premature coronary artery disease could improve the predictive value of the Atherosclerotic Cardiovascular Disease risk estimator and the Systematic COronary Risk Evaluation model. Methods: The case-control study included 307 women with coronary artery disease aged 55 or less, and 347 agematched controls without coronary artery disease. Diagnostic accuracy parameters were evaluated for traditional risk models versus those enriched with menopausal status. Early and late postmenopausal periods were defined as <= 3 and >3 years from the onset of menopause, respectively. Results: Only the addition of the presence of the early postmenopausal stage to the 10-year Atherosclerotic Cardiovascular Disease risk classes resulted in significantly increased c-statistics from 0.66 (95% confidence interval [CI] 0.62-0.7) to 0.705 (95% CI 0.66-0.75) (P = 0.0003) and an increase in accuracy from 61.3% to 63.8% (P = 0.0025). Adding the presence of early postmenopause to the Systematic COronary Risk Evaluation risk classes also resulted in significantly increased c-statistics from 0.59 (95% CI 0.55-0.63) to 0.641 (95% CI 0.6-0.68) (P = 0.0024) and an increase of accuracy from 64.1% versus 57.5% (P = 0.001). Conclusion: Adding the early menopausal period may significantly improve the predictive value of the 10-year Atherosclerotic Cardiovascular Disease risk score and the Systematic COronary Risk Evaluation model in women with premature coronary artery disease.
- 1 April 2018
- Published by Wolters Kluwer Health in Menopause
- Vol. 25 (4) , 408-414
Menopause improves the predictive value of common cardiovascular risk scores in women with premature coronary artery disease
Objective: Menopause, particularly its early stage (<= 3 years from onset), may be an important risk factor for premature coronary artery disease. The objective of the study was to assess whether the addition of the presence of menopause in women with premature coronary artery disease could improve the predictive value of the Atherosclerotic Cardiovascular Disease risk estimator and the Systematic COronary Risk Evaluation model. Methods: The case-control study included 307 women with coronary artery disease aged 55 or less, and 347 agematched controls without coronary artery disease. Diagnostic accuracy parameters were evaluated for traditional risk models versus those enriched with menopausal status. Early and late postmenopausal periods were defined as <= 3 and >3 years from the onset of menopause, respectively. Results: Only the addition of the presence of the early postmenopausal stage to the 10-year Atherosclerotic Cardiovascular Disease risk classes resulted in significantly increased c-statistics from 0.66 (95% confidence interval [CI] 0.62-0.7) to 0.705 (95% CI 0.66-0.75) (P = 0.0003) and an increase in accuracy from 61.3% to 63.8% (P = 0.0025). Adding the presence of early postmenopause to the Systematic COronary Risk Evaluation risk classes also resulted in significantly increased c-statistics from 0.59 (95% CI 0.55-0.63) to 0.641 (95% CI 0.6-0.68) (P = 0.0024) and an increase of accuracy from 64.1% versus 57.5% (P = 0.001). Conclusion: Adding the early menopausal period may significantly improve the predictive value of the 10-year Atherosclerotic Cardiovascular Disease risk score and the Systematic COronary Risk Evaluation model in women with premature coronary artery disease.
- 1 October 2016
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 12 (9) , 1194
Large left lung mass: an unexpected finding
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 October 2016
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 12 (9) , 1194
Large left lung mass: an unexpected finding
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Interventional Cardiology
- Vol. 2, 135-139
Pulmonary artery rupture as a complication of Swan-Ganz catheter application. Diagnosis and endovascular treatment: a single centre’s experience
Introduction: The placement of a Swan-Ganz catheter into the pulmonary artery may lead to a number of complications (2–17%). In less than 0.2% of cases Swan-Ganz catheterization results in serious vascular damage – pulmonary artery rupture (PAR). This paper presents two distinct forms of...
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Interventional Cardiology
- Vol. 2, 135-139
Pulmonary artery rupture as a complication of Swan-Ganz catheter application. Diagnosis and endovascular treatment: a single centre’s experience
Introduction: The placement of a Swan-Ganz catheter into the pulmonary artery may lead to a number of complications (2–17%). In less than 0.2% of cases Swan-Ganz catheterization results in serious vascular damage – pulmonary artery rupture (PAR). This paper presents two distinct forms of...
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Interventional Cardiology
- Vol. 1, 57-60
Noninvasive pacing during transfemoral implantation of the Edwards SAPIEN valve for tricuspid valve bioprosthesis stenosis
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Interventional Cardiology
- Vol. 1, 57-60
Noninvasive pacing during transfemoral implantation of the Edwards SAPIEN valve for tricuspid valve bioprosthesis stenosis
- 22 June 2015
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 73 (6) , 460
An unexpected cause of recurrent ST-elevation myocardial infarction with normal coronary angiography in a 48-year-old female
- 22 June 2015
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 73 (6) , 460
An unexpected cause of recurrent ST-elevation myocardial infarction with normal coronary angiography in a 48-year-old female
- 1 August 2014
- Published by Elsevier in JACC: Heart Failure
- Vol. 2 (4) , 335-343
Exercise Capacity and Mortality in Patients With Ischemic Left Ventricular Dysfunction Randomized to Coronary Artery Bypass Graft Surgery or Medical Therapy
- 1 August 2014
- Published by Elsevier in JACC: Heart Failure
- Vol. 2 (4) , 335-343
Exercise Capacity and Mortality in Patients With Ischemic Left Ventricular Dysfunction Randomized to Coronary Artery Bypass Graft Surgery or Medical Therapy
- Open Access
- 1 January 2013
- Published by Termedia Sp. z.o.o. in Advances in Interventional Cardiology
- Vol. 1 (1) , 1-8
Lumen and calcium characteristics within calcified coronary lesions. Comparison of computed tomography coronary angiography intravascular ultrasound
Wstęp: Badanie tomografii komputerowej (TK) tętnic wieńcowych stosuje się w celu wykluczenia istotnych zwężeń w tętnicach wieńcowych. Niższa wartość diagnostyczna metody w ocenie zmian uwapnionych stanowi istotny czynnik ograniczający zastosowanie TK w ocenie osób z chorobą...
- 1 January 2013
- Published by Termedia Sp. z.o.o. in Advances in Interventional Cardiology
- Vol. 1 (1) , 1-8
Open AccessLumen and calcium characteristics within calcified coronary lesions. Comparison of computed tomography coronary angiography intravascular ultrasound
Wstęp: Badanie tomografii komputerowej (TK) tętnic wieńcowych stosuje się w celu wykluczenia istotnych zwężeń w tętnicach wieńcowych. Niższa wartość diagnostyczna metody w ocenie zmian uwapnionych stanowi istotny czynnik ograniczający zastosowanie TK w ocenie osób z chorobą...
- Open Access
- 4 September 2011
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 32 (23) , 2988
Normal chest radiograph and ground glass opacities on a thoracic computed tomographic scan in a patient with diffuse alveolar haemorrhage due to dual antiplatelet therapy prescribed after patent foramen ovale percutaneous device closure
A 40-year-old woman was re-admitted due to haemoptysis 6 days after her patent foramen ovale (PFO) was successfully closed with the Amplatzer® PFO Occluder. Initially, a combination of aspirin (75 mg per day) and clopidogrel (75 mg per day) was given to protect against thrombus formation on the device. She complained of a cough but without dyspnoea. She presented normotensive and her pulse rate was not elevated. Oxygen saturations and her temperature were normal. Discontinuous soft crepitations were heard at the right lung base. White blood cell count, erythrocyte sedimentation rate, and high-sensitivity C-reactive protein level were all within normal limits. There was a drop in haemoglobin concentration (13.4 g/dL before PFO closure → 11.9 g/dL at the moment) and falling haematocrit level (40.1 → 34.6%, respectively). Laboratory signs of neither renal impairment nor thrombocytopenia were present. Chest X-ray appeared entirely normal [Panel 1—posteroanterior (PA) projection, Panel 2—a magnified PA view of the right lung base and its lateral aspect—Panel 3]. Thoracic computed tomographic scan demonstrated unilateral ground glass opacities in a posterior (Panel A—‘P’), lateral (Panel A—‘L’), and medial (Panel A—‘M’) basal segments of the right lung. These were attributed to bleeding into the alveolar spaces, affecting ∼20% of the right lung (Panel B). Correct occluder position was verified (arrows on Panels 3 and A). Diffuse alveolar haemorrhage (DAH) was diagnosed, with bleeding through alveolar-capillary membrane without its inflammation or destruction. Its pathogenesis was attributed to a coagulation disorder related to potent dual antiplatelet therapy. Clopidogrel was withdrawn and haemoptysis stopped. Aspirin alone was given (150 mg per day) and 6-month follow-up was uneventful. Various transcatheter closure device protocols are in routine use worldwide. The combination of aspirin and clopidogrel is regularly scheduled after percutaneous device closure procedures and we should be aware of the DAH syndrome as its potential life-threatening complication.
- 4 September 2011
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 32 (23) , 2988
Open AccessNormal chest radiograph and ground glass opacities on a thoracic computed tomographic scan in a patient with diffuse alveolar haemorrhage due to dual antiplatelet therapy prescribed after patent foramen ovale percutaneous device closure
A 40-year-old woman was re-admitted due to haemoptysis 6 days after her patent foramen ovale (PFO) was successfully closed with the Amplatzer® PFO Occluder. Initially, a combination of aspirin (75 mg per day) and clopidogrel (75 mg per day) was given to protect against thrombus formation on the device. She complained of a cough but without dyspnoea. She presented normotensive and her pulse rate was not elevated. Oxygen saturations and her temperature were normal. Discontinuous soft crepitations were heard at the right lung base. White blood cell count, erythrocyte sedimentation rate, and high-sensitivity C-reactive protein level were all within normal limits. There was a drop in haemoglobin concentration (13.4 g/dL before PFO closure → 11.9 g/dL at the moment) and falling haematocrit level (40.1 → 34.6%, respectively). Laboratory signs of neither renal impairment nor thrombocytopenia were present. Chest X-ray appeared entirely normal [Panel 1—posteroanterior (PA) projection, Panel 2—a magnified PA view of the right lung base and its lateral aspect—Panel 3]. Thoracic computed tomographic scan demonstrated unilateral ground glass opacities in a posterior (Panel A—‘P’), lateral (Panel A—‘L’), and medial (Panel A—‘M’) basal segments of the right lung. These were attributed to bleeding into the alveolar spaces, affecting ∼20% of the right lung (Panel B). Correct occluder position was verified (arrows on Panels 3 and A). Diffuse alveolar haemorrhage (DAH) was diagnosed, with bleeding through alveolar-capillary membrane without its inflammation or destruction. Its pathogenesis was attributed to a coagulation disorder related to potent dual antiplatelet therapy. Clopidogrel was withdrawn and haemoptysis stopped. Aspirin alone was given (150 mg per day) and 6-month follow-up was uneventful. Various transcatheter closure device protocols are in routine use worldwide. The combination of aspirin and clopidogrel is regularly scheduled after percutaneous device closure procedures and we should be aware of the DAH syndrome as its potential life-threatening complication.